BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10

• Press Releases

  Zenas BioPharma Announces Data from the Registrational Phase 3 INDIGO Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD), Simultaneously Presented at the EULAR 2026 Congress and Published in the New England Journal of Medicine

  June 3, 2026

   · 

  14 min read
• Press Releases

  Johnson & Johnson presents new data further reinforcing the role of nipocalimab in lowering the autoantibodies driving Sjögren’s disease

  June 3, 2026

   · 

  12 min read
• Press Releases

  Agilent Receives FDA Approval for Expanded Use of PD-L1 IHC 22C3 pharmDx on Dako Omnis in Esophageal Squamous Cell Carcinoma, Triple-Negative Breast Cancer, Cervical Cancer, and Gastric or Gastroesophageal Junction Adenocarcinoma

  June 3, 2026

   · 

  4 min read
• Press Releases

  DBV Technologies Announces First Participant Screened in THRIVE Phase 2 Study of the VIASKIN® Peanut Patch in Infants ages 6 through 12 Months with Peanut Allergy

  June 3, 2026

   · 

  6 min read
• Press Releases

  Agenus Announces Virtual 2026 Annual Shareholders Meeting

  June 3, 2026

   · 

  1 min read
• Press Releases

  Chiesi Global Rare Diseases to Launch the Second Edition of Find For Rare at 2026 ERA Congress to Advance Research in Lysosomal Storage Disorders

  June 3, 2026

   · 

  7 min read
• Press Releases

  JJP Biologics Announces Positive Interim Phase 1b Data for Nebaprubart (JJP-1212), an Anti-CD89 Antagonist, in Linear IgA Disease (LAD)

  June 3, 2026

   · 

  5 min read
• Press Releases

  Antengene to Present First Preclinical Data on ATG-207 (αCD3-TGF-β Bifunctional Fusion Protein) at EULAR 2026

  June 3, 2026

   · 

  5 min read
• Press Releases

  Wegovy® pill launches in the UAE as Novo Nordisk expands global access to obesity care

  June 3, 2026

   · 

  4 min read
• Press Releases

  MindMaze Therapeutics Publishes Invitation to the 2026 Annual General Meeting

  June 3, 2026

   · 

  2 min read